Table 2.
Mobilization of Patients Receiving Mechanical Ventilation Among Selected Observational Studies and Control Groups of Clinical Trials
Observational Studies of Usual Practice | |||
---|---|---|---|
Study/Country/Year | Study Type and No. of Sites | Patients | Mobility Status Achieved and Rehabilitation Delivered |
Berney et al21/Australia/New Zealand/2013 | 1-d point prevalence study in 38 ICUs in 38 hospitals | N = 200 in ICU for > 2 d |
|
Nydahl et al,22/Germany/2014 | 1-d point prevalence study in 116 ICUs in 115 hospitals | N = 401 with ETT |
|
Jolley et al23/United States/2015 | 2-d point prevalence study in 33 ICUs in 17 hospitals | N = 566 (77% with ETT) |
|
Hodgson et al30/Australia/New Zealand/2015 | Prospective cohort (with up to 14 d of evaluation) in 12 ICUs in 12 hospitals | N = 192 with expected MV > 2 d |
|
Control Groups From Clinical Trials With Positive Results | |||
---|---|---|---|
Morris et al40/United States/2008 | Quasi-RCT: usual care in 7 ICUs in 1 hospital | N = 135 in MICU, enrolled within 2 d of MV |
|
Schweickert et al41/United States/2009 | RCT: usual care in 2 MICUs in 2 hospitals | N = 55 with ETT, enrolled within 3 d of MV |
|
Control Groups From Clinical Trials With Negative Results | |||
---|---|---|---|
Denehy et al44/Australia/2013 | RCT: usual care in single ICU | N = 76 in ICU for > 5 d (∼92% MV) |
|
Moss et al45/United States/2015 | RCT: protocolized PT in 5 hospitals | N = 61 enrolled after MV for ≥ 4-5 d |
|
ETT = endotracheal tube; IQR = interquartile range. See Table 1 legend for expansion of other abbreviations.
As reported in the trial, these data are based on a point prevalence evaluation that included 68 patients receiving MV at the study site who were not enrolled in the trial and received usual care.